Jaguar Health Inc - to Report Pivotal Phase 3 Ontarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on or Before July 23
jaguar health公司將於7月23日或之前宣佈其癌症支持治療藥物crofelemer的關鍵3期ontarget試驗結果
Jaguar Health Inc - to Report Pivotal Phase 3 Ontarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on or Before July 23
jaguar health公司將於7月23日或之前宣佈其癌症支持治療藥物crofelemer的關鍵3期ontarget試驗結果
譯文內容由第三人軟體翻譯。